Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
Tetsuhiro Chiba(Chiba University), Osamu Yokosuka(Chiba University)
Cited by 117
Related Papers
New antiviral therapies for chronic hepatitis C
|Hepatology International|2010|105
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
|PLoS ONE|2014|79
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
|PLoS ONE|2013|74
Hepatitis C Virus Nonstructural 5A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4
|The Journal of Infectious Diseases|2011|54
Downregulation of microRNA-431 by human interferon-β inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6
|International Journal of Oncology|2014|44